Denk Dominic, Greten Florian R
Institute for Tumor Biology and Experimental Therapy, Georg-Speyer-Haus, 60596 Frankfurt/Main, Germany; Department of Medicine 1, Goethe-University Hospital Frankfurt, Germany.
Institute for Tumor Biology and Experimental Therapy, Georg-Speyer-Haus, 60596 Frankfurt/Main, Germany; Frankfurt Cancer Institute, Goethe University Frankfurt, 60596 Frankfurt/Main, Germany; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.
Trends Cancer. 2022 Nov;8(11):901-914. doi: 10.1016/j.trecan.2022.07.002. Epub 2022 Jul 28.
An inflammatory microenvironment, either conferred by an underlying chronic overt or smoldering inflammatory condition constitutes a prerequisite and fuel to essentially all cancers. The complex reciprocal interplay of different cell types in the tumor microenvironment (TME) determines patient outcome. Apart from the actual tumor cells, local and recruited nonmalignant cells as well as the intestinal microbiome actively shape polarization and plasticity of cells in the TME, thereby augmenting protumorigenic and prometastatic inflammatory processes. Here, we address the universality of inflammation in carcinogenesis, review distinct forms of tumor related inflammation and highlight critical processes in the TME actively sustaining a nurturing incubator for cancer progression and therapy resistance.
由潜在的慢性显性或隐匿性炎症状态所赋予的炎症微环境,是几乎所有癌症的先决条件和助推因素。肿瘤微环境(TME)中不同细胞类型之间复杂的相互作用决定了患者的预后。除了实际的肿瘤细胞外,局部和募集的非恶性细胞以及肠道微生物群积极塑造TME中细胞的极化和可塑性,从而增强促肿瘤和促转移的炎症过程。在此,我们探讨炎症在致癌作用中的普遍性,回顾肿瘤相关炎症的不同形式,并强调TME中积极维持癌症进展和治疗抗性的滋养温床的关键过程。